[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370187-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-370187-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","cryb2-alters-cell-adhesion-to-promote-invasion-in-a-triple-negative-breast-cancer-cell-line","CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line","","Objective: African American women with breast cancer experience disproportionately poor survival, driven largely by the high prevalence of triple-negative breast cancer (TNBC). The CRYβB2 gene is upregulated across breast cancer subtypes in African American patients, including TNBC, and associates with worse outcomes. Results: In SUM159 3D-culture tumor spheroids, CRYβB2 overexpression significantly increased invasion. RNA sequencing showed CRYβB2 modulates cell-cell adhesion and extracellular matrix organization pathways, suppressing clustered protocadherins while promoting PCDH7. PCDH7 knockout reduced CRYβB2-induced invasiveness, linking CRYβB2 to invasion via adhesion protein regulation.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cryb2-alters-cell-adhesion-to-promote-invasion-in-a-triple-negative-breast-cancer-cell-line/370187/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cryb2-alters-cell-adhesion-to-promote-invasion-in-a-triple-negative-breast-cancer-cell-line/370187.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the study?","Question",{"text":63,"@type":64},"To determine how CRYβB2 affects invasion in TNBC cells and the mechanisms underlying this phenotype.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What model and assay were used to test invasion?",{"text":68,"@type":64},"SUM159 cells with stable CRYβB2 overexpression were studied in a 3D-culture tumor spheroid model using a quantitative 3D invasion assay.",{"name":70,"@type":61,"acceptedAnswer":71},"How does CRYβB2 influence cell adhesion-related pathways?",{"text":72,"@type":64},"CRYβB2 overexpression modulates cell-cell adhesion and extracellular matrix organization pathways by suppressing clustered protocadherins and promoting PCDH7.",{"name":74,"@type":61,"acceptedAnswer":75},"What happens when PCDH7 is knocked out?",{"text":76,"@type":64},"PCDH7 knockout diminishes the invasive capacity induced by CRYβB2 in the TNBC model.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},370187,1790713189,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":119,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":33,"preview_urls":149},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Waly et al. BMC Research Notes (2025) 18:26 [https://doi.org/10.1186/s13104-025-07090-w](https://doi.org/10.1186/s13104-025-07090-w)  \nBMC Research Notes  \nRESEARCH NOTE Open Access  \nCRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line  \nAmr A. Waly 1, London Harper 1, Jodie M. Fleming 1,2 and Lindsey M. Costantini 1*  \nAbstract  \nObjective African American women with breast cancer experience disproportionately poor survival outcomes, primarily due to the high prevalence of the deadliest subtype; triple-negative breast cancer (TNBC) . The CRYβB2 gene is upregulated in tumors from African American patients across all breast cancer subtypes, including TNBC, and is associated with worse survival rates. This study investigated the effect of CRYβB2 on the invasion ofTNBC cells and the underlying mechanisms contributing to this phenotype.  \nResults We utilized the SUM159 cells with stable CRYβB2 overexpression in a 3D-culture tumor spheroids model in our investigation. A quantitative 3D invasion assay demonstrated that CRYβB2 overexpression significantly enhanced invasion (median invasion %; SUM159 = 0.14 and SUM159 +CRYβB2 = 0 . 33) . RNA sequencing analysis indicated that CRYβB2 overexpression modulated cell-cell adhesion and extracellular matrix organization pathways, which are critical to invasion of cancer cells. Specifically, CRYβB2 suppressed the expression of key cell-cell adhesion genes known as clustered protocadherins and promoted the expression of PCDH7, a nonclustered protocadherin with known oncogenic roles in various cancers. Notably, the knockout of PCDH7 diminished the invasive capacity induced by CRYβB2 (median invasion %; SUM159 = 0 . 093, SUM159 +CRYβB2 = 0.184 and SUM159 +CRYβB2/PCDH7−/−=0 . 082) . These findings provide a novel link between a previously identified differential ly expressed gene, CRYβB2, in driving breast cancer phenotypes by modulating a class of adhesion proteins.  \nKeywords Cancer disparities, Triple negative breast cancer, CRYβB2, Invasion, Protocadherins  \nThis work was prepared while Jodie Fleming was employed at North Carolina Central University. The opinions expressed in this article are the author’s own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government.  \n*Correspondence:  \nLindsey M. Costantini  \n[lmcostantini@nccu.edu](lmcostantini@nccu.edu)  \n1Biological and Biomedical Sciences Department, University of North Carolina Central University, Durham, NC 27707, USA  \n2Present address: National Institutes of Health, Bethesda, MD 20892, USA  \nIntroduction  \nBreast cancer (BC) is the most prevalent type of cancer among women; however, African American (AA) BC patients experience higher mortality rates compared to their European American (EA) counterparts. Despite advancements in therapeutic options and improved survival rates for both races, this survival disparity persists [1, 2]. In addition to socioeconomic factors, the higher incidence of the most lethal BC subtype—triple-negative breast cancer (TNBC)—among premenopausal AA patients significantly contributes to these varied survival outcomes [3, 4]. Tumors ofthis subtype are characterized  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If mater","cbCaio2esNOvMGPW","https://ap.wps.com/l/cbCaio2esNOvMGPW","pdf",1265873,"English","# Abstract\n## Objective\n## Results\n# Introduction\n## Breast cancer disparities and TNBC\n## Role of CRYβB2\n# Methods\n## Cell lines and generation of expression models","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To determine how CRYβB2 affects invasion in TNBC cells and the mechanisms underlying this phenotype.\"},{\"question\":\"What model and assay were used to test invasion?\",\"answer\":\"SUM159 cells with stable CRYβB2 overexpression were studied in a 3D-culture tumor spheroid model using a quantitative 3D invasion assay.\"},{\"question\":\"How does CRYβB2 influence cell adhesion-related pathways?\",\"answer\":\"CRYβB2 overexpression modulates cell-cell adhesion and extracellular matrix organization pathways by suppressing clustered protocadherins and promoting PCDH7.\"},{\"question\":\"What happens when PCDH7 is knocked out?\",\"answer\":\"PCDH7 knockout diminishes the invasive capacity induced by CRYβB2 in the TNBC model.\"}]","CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line | PDF",1790187227,23,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0cf8c0898a12985f4867ad4e61b70f3.webp",983,1310,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b864bc4f75e8c0c028a6978489d2b9a.webp",982,1309,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4d7c01b2e1b736bded913c0bf5a2369.webp",981,1308,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0738c56810edcd3fd808f1ed3bf30b9.webp",980,1306]